Migraine with or without aura, susceptibility to, 3

disease
On this page

Also known as MGR3migraine with or without aura, susceptibility to, type 3

Summary

Migraine with or without aura, susceptibility to, 3 (MONDO:0011845) is a disease. A subtype of migraine with or without aura, susceptibility to — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namemigraine with or without aura, susceptibility to, 3
Mondo IDMONDO:0011845
OMIM607498
UMLSC1843782
MedGen375283
Is cancer (heuristic)no

Also known as: MGR3 · migraine with or without aura, susceptibility to, 3 · migraine with or without aura, susceptibility to, type 3

Disease family

This is a subtype of migraine with or without aura, susceptibility to. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease susceptibility › inherited disease susceptibilitymigraine with or without aura, susceptibility tomigraine with or without aura, susceptibility to, 3

Related subtypes (12): migraine with or without aura, susceptibility to, 1, migraine, familial typical, susceptibility to, 2, migraine without aura, susceptibility to, 4, migraine with or without aura, susceptibility to, 5, migraine with or without aura, susceptibility to, 6, migraine with aura, susceptibility to, 7, migraine with or without aura, susceptibility to, 8, migraine with aura, susceptibility to, 9, migraine with or without aura, susceptibility to, 10, migraine with or without aura, susceptibility to, 11, migraine with or without aura, susceptibility to, 12, migraine, with or without aura, susceptibility to, 13

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.